Ace:
News

Research

A new drug for Alzheimer's could reach the market in 2023

28/09/2022
The pharmaceutical companies Eisai and Biogen have just announced to the press the results of their monoclonal antibody Lecanemab, a drug targeted at the deposit of amyloid in the brain.

Two posters of the FACEHBI study will be presented to the eighth Conference Clinical Trials on Alzheimer's Disease in November

28/10/2015Research
Fundació ACE will present two posters of the "Fundació ACE Healthy Brain Initiative" study. In both of them have participated researchers from F...

Tordera against Alzheimer's

27/10/2015Awareness
On the occasion of the World Alzheimer's Day, Residència L'Albert organized a whole day of activities with the aim of raising awareness about the di...

The II edition of Estimul'Art programme begins

24/10/2015SCR
The second edition of Estimul'art began on October 16 and will last until May 6. Organizers -Foundation ACE, Frederic Marès Museum and the Museum of ...

Interview with Dr. Boada at the radio “La Xarxa”

28/01/2015Awareness
How do we know if a person has Alzheimer’s? Which is the social awareness about the disease? How can we take care of our memory? It is true that exe...